Although the Wnt/β-catenin and PI3K/AKT signaling pathways were investigated separately and showed promising results, our work revealed that combined suppression of these two signaling pathways, which are involved in the development of EM, can have a more significant impact. The gene discussed is AKT1; the disease is erythema multiforme.